All In MedTech

Device Trial Radar · NCT03821142

Prospective Long-term Evaluation of the Efficacy and Safety of Calistar S for Transvaginal Pelvic Organ Prolapse Repair

Prospective, Multicenter, 60 Months, Single Arm Cohort Study to Evaluate the Efficacy and Safety of the Ultra-Light-Weight Mesh CAlistar S in Transvaginal Pelvic Organ Prolapse Repair

Last checked: Nov 20, 2026Latest source record: Nov 22, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

180

Planned (sponsor's estimate)

Start

Mar 10, 2021

Primary completion

Oct 2026

Study completion Oct 2029

Sponsor

Lead sponsor
PromedonNot on our public-company list
Sponsor type
Industry
First posted
Jan 29, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Prospective long-term evaluation of the performance and safety of Calistar S for transvaginal pelvic organ prolapse repair in women with anterior POP with or without apical vaginal involvement

Conditions

  • Pelvic Organ Prolapse

Interventions

  • Transvaginal mesh for anterior pelvic organ prolapse repairDevice

    synthetic mesh for anterior pelvic organ prolapse with or without apical vaginal wall involvement via the vaginal route in a highly selected patient population

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Patients with Cure of pelvic organ prolapseTime frame: 24 months

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • St. Hedwig Hospital

    Berlin, Germany

  • Evangelic Diakonie Hospital

    Freiburg im Breisgau, Germany

  • St. Elisabeth-Hospital Leipzig

    Leipzig, Germany

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.